Back to search

National and Kapodistrian University of Athens

Μελέτη του προστατευτικού ρόλου των αναστολέων των μεταλλοπρωτεϊνασών (στατίνη, περινδοπρίλη) στην αναστολή της αθηρωμάτωσης και της δημιουργίας ανευρυσμάτων της θωρακικής αορτής

Abstract

dc:description

INTRODUCTION. An aortic aneurysm is defined as the dilation of one or more segments of the aorta to greater than 1.5 times normal size. Although usually asymptomatic, it is associated with high mortality and morbidity rates due to the risk of rupture or dissection. The pathophysiology of the thoracic aortic aneurysm (TAA) is complex and multifactorial, involving biomechanical, inflammatory, genetic, and environmental factors. Up to date, the gold standard for treatment of a non-ruptured aneurysm is the surgical or endovascular repair. Although some clinical studies aimed to discover potential pharmaceutical agents that could be used protectively against aneurysmal dilation of the aorta, there is no sufficient evidence yet. Perindopril is an angiotensin-converting enzyme inhibitor (ACE-i) that is primarily utilized as anti-hypertensive and has been associated with decreased mortality in patients with cardiovascular disease. Simvastatin is a β-Hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase inhibitor. Τhere is substantial evidence that statins exert specific effects other than the lipid-lowering ones, mainly associated with anti-inflammatory properties.Our study aimed to investigate the role of perindopril and simvastatin in an experimental model of TAA and their implication in the inflammatory process and tissue remodeling. MATERIAL AND METHODSAnimal model and study designEight-week-old New Zealand male adult rabbits weighing 3-4 kg were obtained from a certified breeding farm in Greek territory. Thirty-nine rabbits were allocated into 4 groups: (a) Control group (n=6) – animals were subjected to posterolateral thoracotomy and normal saline application on the wall of their descending thoracic aorta (sham surgery); (b) CaCl2 group (n=15) – animals underwent posterolateral thoracotomy, and a solution of 0.5 mol/L CaCl2 was applied on the descending thoracic aorta; (c) simvastatin group (n=9) – animals were treated with 2.5 mg/kg/day per os in addition to the application of CaCl2 solution; and(d) perindopril group (n=9) – animals were treated with 0.3 mg/kg/day in addition to the application of CaCl2 solution. The simvastatin and perindopril groups received the respective regimen for one week before and 11 weeks after the operative procedure. RESULTS. Aortic diameter and wall thicknessCaCl2 application on the aortas led to an average of 21% increase in diameter compared to the cohort of untreated animals (4,876617 μm vs. 3,856604 μm, respectively; p=0.014). Treatment with either simvastatin or perindopril significantly attenuated the effect of CaCl2 (4,145484 μm; p=0.039, and 4,209280 μm; p=0.05, respectively, compared with the CaCl2 group) . Wall thickness did not differ among groups (p>0.05 in all cases). Atherosclerosis and plaque formationAortas treated with CaCl2 presented apparent atherosclerosis in 75% of the cases as opposed to only 20% of the control aortas . Administration of simvastatin to CaCl2 treated rabbits was associated with atherosclerosis progression in only 30% of the cases, whereas this percentage was 20% in the perindopril-treated group . Mean plaque thickness was higher in the CaCl2 group when compared with the control, simvastatin, and perindopril group (134157 μm vs. 1326 μm vs. 3264 μm vs. 4283 μm, respectively) . However, statistical significance was not achieved in the observations above due to the wide range and standard deviation of the distributions. IL-6 and MMP-9 expression. The expression of IL-6 and MMP-9 on the aortic wall was evaluated with immunostaining of the aortic segments . Neither intensity nor extent of MMP-9 expression differed among groups . On the other hand, intensity of IL-6 expression was lower in both the simvastatin and perindopril-treated groups compared with the CaCl2 group (p=0.01 in both cases).ConclusionThe primary outcomes of our study are the protective role of perindopril and simvastatin against TAA formation and progression via down-regulation of local inflammation on the aortic wall. Secondary outcomes include: (i) the feasibility and efficacy of CaCl2 periaortic application in the descending thoracic aorta of rabbits as an experimental model of aneurysm formation, and (ii) the loss of association between aortic diameter and wall thickness in the drug-treated groups. Yet, this is an experimental study, and further translational and basic research studies are required to verify our findings.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Androutsopoulou, Vasiliki
  • Ανδρουτσοπούλου, Βασιλική

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43800

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Androutsopoulou, Vasiliki; Ανδρουτσοπούλου, Βασιλική. Μελέτη του προστατευτικού ρόλου των αναστολέων των μεταλλοπρωτεϊνασών (στατίνη, περινδοπρίλη) στην αναστολή της αθηρωμάτωσης και της δημιουργίας ανευρυσμάτων της θωρακικής αορτής. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/43800